Clinical Trial Update: The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability and pharmacokinetic study of Yimitasvir in healthy adult subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Yimitasvir

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Chronic Hepatitis c | Phase 1 | Status: COMPLETED